CCRN vs. NVEE, AMN, MD, LH, DGX, DVA, CHE, CRVL, AMED, and HSII
Should you be buying Cross Country Healthcare stock or one of its competitors? The main competitors of Cross Country Healthcare include NV5 Global (NVEE), AMN Healthcare Services (AMN), Pediatrix Medical Group (MD), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), and Heidrick & Struggles International (HSII).
Cross Country Healthcare vs. Its Competitors
NV5 Global (NASDAQ:NVEE) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.
75.5% of NV5 Global shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 12.4% of NV5 Global shares are owned by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
NV5 Global has higher earnings, but lower revenue than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than NV5 Global, indicating that it is currently the more affordable of the two stocks.
NV5 Global presently has a consensus target price of $25.67, suggesting a potential upside of 10.54%. Cross Country Healthcare has a consensus target price of $17.93, suggesting a potential upside of 36.97%. Given Cross Country Healthcare's higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than NV5 Global.
In the previous week, NV5 Global had 4 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for NV5 Global and 2 mentions for Cross Country Healthcare. NV5 Global's average media sentiment score of 0.48 beat Cross Country Healthcare's score of 0.20 indicating that NV5 Global is being referred to more favorably in the media.
NV5 Global has a net margin of 3.19% compared to Cross Country Healthcare's net margin of -1.41%. NV5 Global's return on equity of 9.12% beat Cross Country Healthcare's return on equity.
NV5 Global has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500.
Summary
NV5 Global beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.
Get Cross Country Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cross Country Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:CCRN) was last updated on 7/3/2025 by MarketBeat.com Staff
Free CCRN Stock Alerts